Regeneron gets another CRL, predicts delayed August PDUFA for Eylea HDnews2025-08-01T11:37:56+00:00August 1st, 2025|Endpoints News|
Novo Nordisk’s shakeup goes beyond a new CEO; Former FDAer snags regulatory role at GSKnews2025-08-01T11:00:23+00:00August 1st, 2025|Endpoints News|
Bayer says pharma sales exceed expectations, bumps full-year guidancenews2025-08-01T10:47:58+00:00August 1st, 2025|Endpoints News|
FDA approves Lenz’s eye drop for presbyopia, a tricky market for other biopharmasnews2025-07-31T20:56:20+00:00July 31st, 2025|Endpoints News|
4DMT’s eye gene therapy cuts need for injections that treat diabetic macular edemanews2025-07-31T20:41:21+00:00July 31st, 2025|Endpoints News|
Merck will shed 6,000 jobs as it eyes $3B in cost cutsnews2025-07-31T20:04:24+00:00July 31st, 2025|Endpoints News|
HRSA unveils pilot program for 340B rebate modelnews2025-07-31T19:49:42+00:00July 31st, 2025|Endpoints News|
FDA chief wants more harmony between CBER and CDERnews2025-07-31T19:48:19+00:00July 31st, 2025|Endpoints News|
Trump demands pharma CEOs implement ‘most favored nation’ pricing within 60 daysnews2025-07-31T18:19:26+00:00July 31st, 2025|Endpoints News|
Sword moves beyond digital physical therapynews2025-07-31T16:06:12+00:00July 31st, 2025|Endpoints News|
